Propionic Acid

Propionic Acid

SCHEMBL4938562

CCC(=O)O.CCCCCCCCCCCC(C)(C)N.[NaH]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 4/20 0.46
FDPS P14324 1/20 0.46
GPR84 Q9NQS5 6/20 0.45
PPARG P37231 6/20 0.45
PPARD Q03181 6/20 0.45
PPARA Q07869 6/20 0.45
HDAC11 Q96DB2 5/20 0.45
TSHR P16473 4/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
PTPN1 P18031 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45
MEN1 O00255 1/20 0.45
ESR1 P03372 1/20 0.45
ALOX15 P16050 1/20 0.45
PDE4A P27815 1/20 0.45
KMT2A Q03164 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL27083092 0.90 SMPD1 (0.50) SMPD1FDPSGPR84PPARGPPARD
Propionic Acid SCHEMBL4938555 0.89 SMPD1 (0.41) SMPD1FDPSGPR84PPARGPPARD
Glycolic Acid SCHEMBL23466939 0.88 SMPD1 (0.46) SMPD1FDPSGPR84PPARGPPARD
Glycolic Acid SCHEMBL6347459 0.88 SMPD1 (0.46) SMPD1FDPSGPR84PPARGPPARD
Acetic Acid SCHEMBL11691620 0.88 SMPD1 (0.48) SMPD1FDPSGPR84PPARGPPARD
Acetic Acid SCHEMBL9224621 0.88 SMPD1 (0.48) SMPD1FDPSGPR84PPARGPPARD
Acetic Acid SCHEMBL4367052 0.88 SMPD1 (0.48) SMPD1FDPSGPR84PPARGPPARD
Acetic Acid SCHEMBL3139399 0.88 SMPD1 (0.48) SMPD1FDPSGPR84PPARGPPARD
Bicarbonate SCHEMBL1689393 0.87 FDPS (0.48) SMPD1FDPSGPR84PPARGPPARD
Heptanoate SCHEMBL3412856 0.86 GPR84 (0.65) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3007738-B1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM SYNTHETIZED FROM A BIFUNCTIONAL MOLECULE BIOWINTECH (FR) 2020-11-25 EP disclosed
US-9855373-B2 Implantable material grafted with a cell antiproliferative and/or antibacterial film synthetized from a bifunctional molecule BIOWINTECH (FR) 2018-01-02 US disclosed
EP-2861268-B1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM AND PROCESS OF GRAFTING THEREOF COMMISSARIAT L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2017-08-09 EP disclosed
US-20160129166-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM SYNTHETIZED FROM A BIFUNCTIONAL MOLECULE COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (CEA) (FR) 2016-05-12 US disclosed
EP-3007738-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM SYNTHETIZED FROM A BIFUNCTIONAL MOLECULE Biowintech (FR) 2016-04-20 EP disclosed
US-20150174298-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM AND PROCESS OF GRAFTING THEREOF BIOWINTECH (FR) 2015-06-25 US disclosed
EP-2861268-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM AND PROCESS OF GRAFTING THEREOF Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) 2015-04-22 EP disclosed
WO-2014198902-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM SYNTHETIZED FROM A BIFUNCTIONAL MOLECULE BIOWINTECH (FR) 2014-12-18 WO disclosed
EP-2813249-A1 Implantable material grafted with a cell antiproliferative and/or antibacterial film synthetized from a bifunctional molecule Biowintech (FR) 2014-12-17 EP disclosed
WO-2013186388-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM AND PROCESS OF GRAFTING THEREOF COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (CEA) (FR) 2013-12-19 WO disclosed
EP-2674173-A1 Implantable material grafted with a cell antiproliferative and/or antibacterial film and process of grafting thereof COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2013-12-18 EP disclosed
US-8206570-B2 Includes electrolysis of a solution containing an adhesion primer in contact with a surface followed by a reaction at the surface obtained, of a solution containing a protic solvent, and a radically polymerizable monomer COMMISSARIAT A L'ENERGIE ATOMIQUE, ETABLISSEMENT PUBLIC A CARACTERE INDUSTRIEL ET COMMERCIAL (FR) 2012-06-26 US disclosed
US-20080087550-A1 PROCESS FOR FORMING ORGANIC FILMS ON ELECTRICALLY CONDUCTIVE OR SEMI-CONDUCTIVE SURFACES USING AQUEOUS SOLUTIONS IN TWO STEPS COMMISSARIAT A L' ENERGIE ATOMIQUE, Etablissement Public a caractere Industriel et Commercial (FR) 2008-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160129166-A1 IMPLANTABLE MATERIAL GRAFTED WITH A CELL ANTIPROLIFERATIVE AND/OR ANTIBACTERIAL FILM SYNTHETIZED FROM A BIFUNCTIONAL MOLECULE MKI67, PCNA, MIF SMPD1 2104/4885FDPS 526/4885GPR84 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.